BioWorld MedTech

April 4, 2011

ACOs set to change device maker, customer relationship

ATLANTA – With the impending formation of Accountable Care Organizations (ACOs), med-tech companies will have to alter the way they market their products to customers – because the customers will change. (Medical Device Daily) Read More

Radioembolization, the newest liver cancer-busting treatment

Washington roundup: Matrixx decision could prompt more data dumps in SEC filings

Palomar releases Icon Laser and Optimized Light System

International report: Best Medical Belgium acquires MDS Nordion

Court Report: Medtronic wins suit over Boston Sci heart patents

MDD's Fun Facts

Deals roundup: 3M reports the acquisition of assets from Zargis Medical

HIT roundup: SXC to provide PBM services for Nevada Medicaid program

Financings roundup: Thoratec to redeem all outstanding senior notes

Agreements/contracts: AutoGenomics expands molecular testing with PGXL

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...